ProQR (PRQR)
1.28
-0.05 (3.76%)
Upcoming Events
Latest Headlines
ProQR Therapeutics N.V. (PRQR) PT Lowered to $8 at H.C. Wainwright
October 1, 2026 6:58 AM - StreetInsider
ProQR Therapeutics N.V. (PRQR) Reiterated at Market Outperform by Citizens Ahead of Ph1 Readouts
October 1, 2026 4:14 AM - StreetInsider
Form 6-K ProQR Therapeutics N.V. For: Sep 23
September 23, 2026 8:00 AM - SEC Filing
ProQR names new AI chief and adds Hugging Face co-founder to board
September 23, 2026 8:00 AM - StreetInsider
ProQR Announces Appointment of Chris Hart as Chief Data and AI Officer and Thomas Wolf to join the Board of Directors as Strategic AI Advisor
September 23, 2026 8:00 AM - StreetInsider
ProQR doses first participant in Phase 1 trial of AX-0811
September 9, 2026 8:00 AM - StreetInsider
ProQR Announces First Participant Dosed in Phase 1 Study of AX-0811 and Virtual Investor and Analyst Educational Event on September 30, 2026
September 9, 2026 8:00 AM - StreetInsider
ProQR to Participate in Upcoming Investor Conferences in September 2026
September 2, 2026 8:00 AM - StreetInsider
BofA Securities Starts ProQR Therapeutics N.V. (PRQR) at Buy
August 20, 2026 7:15 AM - StreetInsider
H.C. Wainwright Reiterates Buy Rating on ProQR Therapeutics N.V. (PRQR)
August 17, 2026 6:52 AM - StreetInsider
Form 6-K ProQR Therapeutics N.V. For: Jun 30
August 13, 2026 7:01 AM - SEC Filing
Form 6-K ProQR Therapeutics N.V. For: Aug 13
August 13, 2026 7:00 AM - SEC Filing
ProQR Announces Second Quarter 2026 Operating and Financial Results
August 13, 2026 7:00 AM - StreetInsider
Form 4 ProQR Therapeutics N.V. For: Jul 31 Filed by: de Boer Daniel Anton
August 3, 2026 4:01 PM - SEC Filing
Form SCHEDULE 13D/A ProQR Therapeutics N.V. Filed by: VAN HERK INVESTMENTS B.V.
July 29, 2026 4:04 PM - SEC Filing
Form SCHEDULE 13G ProQR Therapeutics N.V. Filed by: Aberdeen Group plc
July 29, 2026 9:48 AM - SEC Filing
Full Article List
